BioCentury
ARTICLE | Financial News

Oberland tops target with $425M royalty and credit fund

April 23, 2015 1:25 AM UTC

Oberland Capital raised its first fund, a $425 million healthcare royalty and credit opportunities investment vehicle. The firm, which exceeded its $350 million target, plans to invest the Oberland Capital Healthcare fund in the biopharma, medical device and diagnostic sectors. Individual investments typically will range from $15-$100 million, although Oberland said it has the ability to perform larger transactions. ...